search
Back to results

Diagnostics of Scaphoid Fractures With HRpQCT

Primary Purpose

Scaphoid Fracture, Scafoïd; Fracture

Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
CT
Sponsored by
VieCuri Medical Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Scaphoid Fracture focused on measuring HRpQCT, high resolution quantitative peripheral CT, Xtreme CT scan, CT scan, Diagnoses Disease, Fracture healing

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Phase I - Diagnostic phase

Inclusion criteria

In order to be eligible to participate in Phase I of the study, a subject must meet all of the following criteria:

  1. Adults (18 years or older) who visit the emergency department of the VieCuri Medical Center Venlo with a clinically suspected scaphoid fracture due to a trauma (<1 week after trauma).
  2. Patients who understand the conditions of the study and are willing and able to comply with the scheduled radiographic evaluations and the prescribed treatment and rehabilitation.
  3. Patients who signed the Ethics Committee approved specific informed consent form prior to inclusion.

Exclusion criteria

A potential subject who meets the following criterion will be excluded from participation in this study:

  1. Patients, who as judged by the principal investigator, are mentally compromised or are unlikely to be compliant with the follow-up evaluations schedule.
  2. Patients with a scaphoid fracture at the ipsilateral side in medical history
  3. Pregnancy.

Phase II - Follow-up phase

Inclusion criteria

In order to be eligible to participate in Phase II of the study, a subject must meet all of the following criteria:

  1. Patients who completed Phase I of the study and have a radiographically confirmed scaphoid fracture on CT or HR-pQCT.
  2. Patients who signed the Ethics Committee approved specific informed consent form prior to inclusion.
  3. Conservatively treated scaphoid fractures.

Exclusion criteria

A potential subject who meets the following criterion will be excluded from participation in this study:

  1. Patients, who as judged by the principal investigator, are mentally compromised or are unlikely to be compliant with the follow-up evaluations schedule.
  2. Pregnancy

Sites / Locations

  • VieCuri Medical CentreRecruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Suspected scaphoid fracture

Arm Description

Patients with a suspected scaphoid fracture

Outcomes

Primary Outcome Measures

Scaphoid fracture detected on CT or HRpQCT
Scaphoid fracture detected on CT or HRpQCT, fracture on one of both scans is considered as a scaphoid fracture

Secondary Outcome Measures

Fracture healing using bone parameters of the HRpQCT
Fracture healing using HRpQCT
Early change in bone strength as a predictive value for long term (26weeks) functional outcome
Estimation of bone strengths by micro-finite element analysis (µFEA)
Early change in trabecular structure parameters measured by HRpQCT as a predictive value for long term functional outcome (26weeks)
Bone micro-architectural parameters are measured by HR-pQCT
Early change in cortical structure parameters measured by HRpQCT as a predictive value for long term functional outcome (26weeks)
Bone micro-architectural parameters are measured by HR-pQCT

Full Information

First Posted
December 20, 2017
Last Updated
March 29, 2019
Sponsor
VieCuri Medical Centre
search

1. Study Identification

Unique Protocol Identification Number
NCT03899025
Brief Title
Diagnostics of Scaphoid Fractures With HRpQCT
Official Title
Diagnostics of Scaphoid Fractures With High-Resolution Peripheral Quantitative Computed Tomography - Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Unknown status
Study Start Date
December 12, 2017 (Actual)
Primary Completion Date
November 28, 2019 (Anticipated)
Study Completion Date
April 28, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
VieCuri Medical Centre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The scaphoid bone is the most common fractured carpal bone. Scaphoid fractures represent 2-6% of all fractures and occur mainly in young, active patients aged 15 to 40. The scaphoid bone has an essential role in functionality of the wrist, acting as a pivot. Correct treatment of a scaphoid fracture depends on accurate and timely diagnosis, and inadequate treatment can result in avascular necrosis (up to 40%), nonunion (5-21%) and early osteoarthritis (up to 32%) that may seriously impair wrist function. In addition, impaired consolidation of scaphoid fractures results in longer immobilization leading to significant functional and psychosocial impairment thus having considerable socio-economic consequences and negative impact on the quality of life. Current diagnostic pathways can take up to two weeks to diagnose (or exclude) a scaphoid fracture, leading to overtreatment in patients with a suspected scaphoid fracture since only 15 to 30% of suspected scaphoid fractures in the Netherlands annually is found to be an actual fracture. Thus, there is significant room for improvement in the diagnostic pathway of scaphoid fractures.
Detailed Description
Scaphoid fractures The scaphoid bone is the most frequently occurring fracture of the carpal bones. Scaphoid fractures represent 2-6% of all fractures and 90% of all carpal fractures in the Netherlands. Scaphoid fractures typically occur in young, active patients aged 15 to 40 years old. The exact incidence is unknown, but approximately 21,000 scaphoid fractures are suspected in the Netherlands each year. However, only 15 to 30% represent real fractures. Because a significant amount of fractures (up to 65% immediately after injury) remain radiographically occult with conventional radiographic imaging, there is a trend of overtreatment of suspected scaphoid fractures, which means a lot of wrists are immobilized unnecessary. A scaphoid fracture has potentially far reaching consequences for the patient, considering the unique nature of this bone in the human body, as it articulates with five surrounding bones in the wrist. Because of this, it has an essential role in functionality of the wrist, acting as a pivot. The treatment of scaphoid fractures is found to be a challenge. Failure can result in avascular necrosis (up to 40%), nonunion (up to 21%) of the fracture and subsequently early osteoarthritis (up to 32%). Displaced fractures of the scaphoid bone can lead to an even higher rate of complications. The results of surgical treatment are variable13 and surgery is often initiated in a late phase of the treatment. Both complicated fracture healing and surgical treatment in a late phase of the treatment have severe socio-economical consequences. Diagnosis and follow up of scaphoid fractures The accurate diagnosis of a scaphoid fracture is the first step of successful treatment of this injury. Delay in treatment has been shown to negatively affect outcome, with adequate treatment of a scaphoid fracture increasing union rates from 55% to 90-100%. However, this knowledge supports the overtreatment-tendency in patients suspected of having a scaphoid fracture at the emergency department. It is estimated that only 15-30% of these patients actually have a scaphoid fracture, 1,3-5 resulting in a substantial number of patients wearing a cast for a limited period of time when they do not need it. As studies have shown, the clinical evaluation directly after trauma is not capable of reliably proving or excluding a scaphoid fracture. Current clinical practice in the Netherlands consists of conventional X-ray, followed by CT one week later when the initial radiographs are negative, but repeated clinical examination does not exclude scaphoid injury. Other imaging modalities such as MRI or bone scintigraphy are also being used. CT scan gives more useful information about the anatomy of a possible fracture and is more easily available in the Dutch situation than MRI and bone scintigraphy. Aside from the diagnostic delay it is difficult to objectify fracture healing with x-ray, CT scan, MRI or bone scintigraphy. Therefore, there is room for improvement of the arsenal to accurately and timely diagnose and classify scaphoid fractures and to evaluate scaphoid fracture healing. High resolution peripheral quantitative computed tomography The current clinical imaging techniques used in the diagnosis of scaphoid fractures as described above lack the resolving power needed for detailed cortical measurements and visualization of the trabecular morphology, for which a spatial resolution lower than 200 µm is needed. The development of high resolution CT scanners with a spatial resolution of 150 to 95 µm enables these measurements, specifically for the extremities. These so-called high-resolution peripheral quantitative CT (HR-pQCT) scanners are smaller and less expensive than current clinical whole body CT scanners. A specific HR-pQCT scanner to visualize and assess trabecular structure of peripheral bones in a clinical (trial) setting is the XtremeCT platform (Scanco Medical AG, Switserland). The most recent iteration of this scanner, the XtremeCT-2, has a voxel size of 61 µm and a spatial resolution of 95 µm, which enables the direct assessment of bone micro-architectural parameters. In addition, after digitalization of the trabecular structure a so called virtual bone biopsy is available, which enables the estimation of bone strength parameters by micro-finite element analysis (µFEA). Validation and reproducibility studies of both the HR-pQCT scanner as well as µFEA have been performed, and in the last decade widespread experience has been gathered concerning the use of these techniques in (clinical) research.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Scaphoid Fracture, Scafoïd; Fracture
Keywords
HRpQCT, high resolution quantitative peripheral CT, Xtreme CT scan, CT scan, Diagnoses Disease, Fracture healing

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
The study will be composed of two subsequent phases, designed to fit within the standard clinical protocol for patients presenting at the emergency department, suspected of having a scaphoid fracture. Briefly, a patient presenting at the emergency department with a clinically suspected scaphoid fracture (by physical examination) will be subjected to standard radiographs followed by cast immobilization. When a fracture is confirmed, a conventional CT is planned within 10 days to assess fracture classification, for which the standard radiographs are insufficient. When no fracture is seen on the initial radiographs, the patient is reevaluated within 10 days after the trauma and physical examination and a conventional CT are performed. Based on the CT, a treatment strategy is decided with regular follow up visits. This clinical workup is in accordance with national and regional treatment protocols, as well as with current literature discussed in sections 1.1 and 1.2.
Masking
None (Open Label)
Allocation
N/A
Enrollment
75 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Suspected scaphoid fracture
Arm Type
Other
Arm Description
Patients with a suspected scaphoid fracture
Intervention Type
Radiation
Intervention Name(s)
CT
Other Intervention Name(s)
HRpQCT
Intervention Description
CT = computed tomography of the hand/wrist HRpQCT = high resolution peripheral quantitative CT scan of the hand/wrist
Primary Outcome Measure Information:
Title
Scaphoid fracture detected on CT or HRpQCT
Description
Scaphoid fracture detected on CT or HRpQCT, fracture on one of both scans is considered as a scaphoid fracture
Time Frame
within 10 days after presentation at the emergency department
Secondary Outcome Measure Information:
Title
Fracture healing using bone parameters of the HRpQCT
Description
Fracture healing using HRpQCT
Time Frame
untill 26weeks after fracture
Title
Early change in bone strength as a predictive value for long term (26weeks) functional outcome
Description
Estimation of bone strengths by micro-finite element analysis (µFEA)
Time Frame
untill 26weeks after fracture
Title
Early change in trabecular structure parameters measured by HRpQCT as a predictive value for long term functional outcome (26weeks)
Description
Bone micro-architectural parameters are measured by HR-pQCT
Time Frame
untill 26weeks after fracture
Title
Early change in cortical structure parameters measured by HRpQCT as a predictive value for long term functional outcome (26weeks)
Description
Bone micro-architectural parameters are measured by HR-pQCT
Time Frame
untill 26weeks after fracture

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Phase I - Diagnostic phase Inclusion criteria In order to be eligible to participate in Phase I of the study, a subject must meet all of the following criteria: Adults (18 years or older) who visit the emergency department of the VieCuri Medical Center Venlo with a clinically suspected scaphoid fracture due to a trauma (<1 week after trauma). Patients who understand the conditions of the study and are willing and able to comply with the scheduled radiographic evaluations and the prescribed treatment and rehabilitation. Patients who signed the Ethics Committee approved specific informed consent form prior to inclusion. Exclusion criteria A potential subject who meets the following criterion will be excluded from participation in this study: Patients, who as judged by the principal investigator, are mentally compromised or are unlikely to be compliant with the follow-up evaluations schedule. Patients with a scaphoid fracture at the ipsilateral side in medical history Pregnancy. Phase II - Follow-up phase Inclusion criteria In order to be eligible to participate in Phase II of the study, a subject must meet all of the following criteria: Patients who completed Phase I of the study and have a radiographically confirmed scaphoid fracture on CT or HR-pQCT. Patients who signed the Ethics Committee approved specific informed consent form prior to inclusion. Conservatively treated scaphoid fractures. Exclusion criteria A potential subject who meets the following criterion will be excluded from participation in this study: Patients, who as judged by the principal investigator, are mentally compromised or are unlikely to be compliant with the follow-up evaluations schedule. Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anne Daniels, MD
Phone
0031773206880
Email
adaniels@viecuri.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Heinrich Janzing, MD, PhD
Organizational Affiliation
VieCuri MC
Official's Role
Principal Investigator
Facility Information:
Facility Name
VieCuri Medical Centre
City
Venlo
State/Province
Limburg
ZIP/Postal Code
5912
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anne Daniels, MD
Phone
0773206880
Email
adaniels@viecuri.nl
First Name & Middle Initial & Last Name & Degree
Heinrich Janzing, MD, PhD
First Name & Middle Initial & Last Name & Degree
Anne Daniels, MD

12. IPD Sharing Statement

Learn more about this trial

Diagnostics of Scaphoid Fractures With HRpQCT

We'll reach out to this number within 24 hrs